India's Alkem Labs accused of fudging trial data by German regulator

MUMBAI (Reuters) - India's Alkem Laboratories has been accused by Germany's health regulator of fudging data on clinical trials of an antibiotic and brain disorder drug, becoming the third Indian firm to be scrutinized since 2014 for suspected manipulation of trial data.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro